Giuseppe Giaccone Selected Research

Giuseppe Giaccone Research Topics

Disease

176	Neoplasms (Cancer) 01/2024 - 01/2002
106	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 02/2002
53	Lung Neoplasms (Lung Cancer) 09/2023 - 10/2002
23	Thymoma (Thymic Carcinoma) 10/2022 - 03/2005
14	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 10/2002
14	Disease Progression 10/2022 - 03/2004
10	Diarrhea 01/2019 - 03/2004
9	Adenocarcinoma 01/2020 - 03/2004
8	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2002
7	Carcinoma (Carcinomatosis) 12/2016 - 07/2002
6	Exanthema (Rash) 01/2019 - 11/2005
6	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018 - 08/2005
5	Thrombocytopenia (Thrombopenia) 11/2014 - 03/2002
4	Thymus Neoplasms (Thymus Neoplasm) 09/2022 - 10/2010
4	Adenocarcinoma of Lung 11/2016 - 01/2012
4	Melanoma (Melanoma, Malignant) 01/2016 - 09/2010
3	Nausea 10/2017 - 03/2002
3	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 11/2005
3	Neutropenia 11/2014 - 06/2007
3	Carcinogenesis 10/2013 - 08/2005
3	Prostatic Neoplasms (Prostate Cancer) 09/2012 - 07/2010
3	Lymphoma (Lymphomas) 01/2012 - 11/2005
3	Malignant Mesothelioma 11/2006 - 10/2005
3	Hypersensitivity (Allergy) 01/2005 - 06/2003
3	Fanconi Anemia (Fanconi's Anemia) 01/2005 - 06/2003
3	Infections 12/2004 - 02/2002
2	Pneumonia (Pneumonitis) 03/2023 - 06/2010
2	Esophageal Neoplasms (Esophageal Cancer) 09/2021 - 04/2006
2	Inflammation (Inflammations) 01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

40	ErbB Receptors (EGF Receptor)IBA 01/2023 - 06/2003
28	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2003
22	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 03/2002
21	Gefitinib (Iressa)FDA Link 01/2023 - 06/2003
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2004
16	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 08/2005
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2008
15	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 08/2005
12	PlatinumIBA 10/2022 - 06/2002
11	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 02/2002
8	Histone Deacetylase InhibitorsIBA 01/2018 - 11/2008
8	Bortezomib (Velcade)FDA Link 09/2009 - 11/2005
7	Monoclonal AntibodiesIBA 10/2020 - 06/2003
7	dacomitinibIBA 01/2019 - 10/2010
7	Phosphotransferases (Kinase)IBA 01/2019 - 01/2002
7	Anaplastic Lymphoma KinaseIBA 05/2016 - 11/2012
7	Gemcitabine FDA Link 04/2012 - 03/2002
7	CaspasesIBA 04/2007 - 02/2002
6	Immune Checkpoint InhibitorsIBA 01/2024 - 02/2014
6	pembrolizumabIBA 01/2022 - 10/2017
6	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2021 - 01/2010
6	LigandsIBA 11/2021 - 12/2002
5	Sunitinib (Sutent)FDA Link 09/2022 - 09/2008
5	atezolizumabIBA 11/2021 - 10/2017
5	Pemetrexed (MTA)FDA Link 06/2019 - 04/2008
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2002
5	belinostatIBA 01/2018 - 05/2011
5	Sorafenib (BAY 43-9006)FDA Link 04/2012 - 09/2009
4	Myeloma ProteinsIBA 12/2023 - 09/2014
4	B7-H1 AntigenIBA 01/2022 - 10/2017
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 11/2013
4	Carboplatin (JM8)FDA LinkGeneric 12/2021 - 03/2004
4	NivolumabIBA 10/2021 - 12/2016
4	AntigensIBA 11/2016 - 09/2011
4	CrizotinibIBA 01/2016 - 01/2012
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2013 - 11/2006
4	MicroRNAs (MicroRNA)IBA 10/2013 - 07/2010
4	Tyrosine (L-Tyrosine)FDA Link 06/2012 - 01/2002
4	Proteasome InhibitorsIBA 11/2007 - 11/2005
3	MesothelinIBA 01/2022 - 05/2015
3	osimertinibIBA 01/2021 - 10/2017
3	Cell-Free Nucleic AcidsIBA 12/2018 - 12/2017
3	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 10/2002
3	STA 9090IBA 01/2018 - 12/2010
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 11/2005
3	VaccinesIBA 01/2016 - 07/2010
3	CytokinesIBA 01/2016 - 12/2004
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016 - 09/2010
3	Bevacizumab (Avastin)FDA Link 10/2015 - 04/2007
3	Docetaxel (Taxotere)FDA Link 10/2015 - 03/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2015 - 10/2002
3	Epidermal Growth Factor (EGF)IBA 04/2014 - 07/2010
3	Peptides (Polypeptides)IBA 06/2012 - 09/2009
3	Imatinib Mesylate (Gleevec)FDA Link 01/2012 - 10/2009
3	EpitopesIBA 09/2011 - 08/2004
3	ParaffinIBA 11/2010 - 01/2007
3	SurvivinIBA 09/2009 - 04/2002
3	Caspase 9IBA 05/2009 - 06/2006
3	Antineoplastic Agents (Antineoplastics)IBA 03/2009 - 01/2002
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2012
2	SNX-5422IBA 12/2021 - 11/2011
2	Dasatinib (BMS 354825)FDA Link 01/2021 - 01/2018
2	citrate-binding transport proteinIBA 01/2020 - 01/2018

Therapy/Procedure

89	Therapeutics 01/2024 - 03/2002
56	Drug Therapy (Chemotherapy) 01/2024 - 03/2002
15	Immunotherapy 03/2023 - 07/2010
11	Radiotherapy 09/2021 - 11/2002
4	Neoadjuvant Therapy 09/2021 - 03/2005
3	Lasers (Laser) 10/2021 - 01/2012
3	Adjuvant Chemotherapy 01/2018 - 10/2003
2	Precision Medicine 10/2021 - 03/2014